Abstract:Betel quid (BQ) chewing increased the risk of oral cancer and oral submucous fibrosis (OSMF), an oral premalignant disorder (OPMD) with malignant transformation potential. BQ components such as areca nut (AN), trauma by coarse AN fiber, catechin, copper, alkaloids, stimulated reactive oxygen species (ROS), inflammation and cytotoxicity are suggested to be the contributing factors. They may induce tissue inflammation, proliferation of fibroblasts and collagen deposition, myofibroblast differentiation and contraction, collagen cross-links and inhibit collagen phagocytosis, finally leading to the development of OSMF and oral cancer. These events are mediated by BQ components-induced changes of extracellular matrix (ECM) turnover via regulation of TGF-β1, plasminogen activator inhibitor-1 (PAI-1), cystatin, lysyl oxidase (LOX) and tissue inhibitors of metalloproteinases (TIMPs) and metalloproteinases (MMPs). Genetic susceptibility is also involved in these disease processes. Further understanding the molecular mechanisms of BQ-induced OSMF and oral cancer can be helpful for future disease prevention and treatment.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the relationship between the genetic susceptibility and protein expression of genes related to extracellular matrix (ECM) turnover in oral submucous fibrosis (OSMF). Specifically, the study focuses on the genetic variations and changes in expression levels of genes related to ECM turnover (such as collagen - related genes, metalloproteinases and their inhibitors, etc.) in OSMF patients, and how these changes affect the occurrence and development of OSMF. In addition, the study also explores the possible roles of these genes in the transformation of OSMF into malignant tumors, aiming to provide a basis for further understanding the molecular mechanisms of OSMF, and thus provide new ideas for the prevention and treatment of the disease. It is mentioned in the article that betel quid (BQ) chewing is one of the main factors leading to OSMF, and the components in BQ (such as areca nut, crude fiber, catechin, copper, etc.) can promote the development of OSMF through mechanisms such as inducing the production of reactive oxygen species (ROS), inflammatory reactions and cytotoxicity. These factors affect the synthesis and degradation of collagen by regulating key molecules in ECM turnover (such as TGF - β1, PAI - 1, Cystatin, Lysyl Oxidase, TIMPs and MMPs, etc.), and ultimately lead to tissue fibrosis and the occurrence of OSMF. At the same time, genetic susceptibility also plays an important role in this process, and different genotypes may make individuals have different susceptibilities to OSMF. Therefore, by in - depth study of the polymorphism and expression patterns of these genes, the pathogenesis of OSMF can be better understood, and scientific basis can be provided for future disease prevention and control strategies.

Genetic Susceptibility and Protein Expression of Extracellular Matrix Turnover-Related Genes in Oral Submucous Fibrosis

Gene Expression Profiling of Oral Submucous Fibrosis Using Oligonucleotide Microarray

Novel genetic biomarkers for susceptibility to oral submucous fibrosis: cytochrome P450 3A.

Identification of a BRAF/PA28γ/MEK1 Signaling Axis and Its Role in Epithelial-Mesenchymal Transition in Oral Submucous Fibrosis

Mechanisms and markers of malignant transformation of oral submucous fibrosis

Discovery of Novel Biomarkers in Oral Submucous Fibrosis by Microarray Analysis

Multiple logistic regression analysis of risk factors for carcinogenesis of oral submucous fibrosis in mainland China.

Low-dose arecoline regulates distinct core signaling pathways in oral submucous fibrosis and oral squamous cell carcinoma

Synergistic effects of betel quid chewing, tobacco use (in the form of cigarette smoking), and alcohol consumption on the risk of malignant transformation of oral submucous fibrosis (OSF): a case-control study in Hunan Province, China

Etiology, pathogenesis, diagnosis and treatment of oral submucous fibrosis

YAP-Induced Endothelial-Mesenchymal Transition in Oral Submucous Fibrosis.

Spatial Transcriptomic and Metabolomic Landscapes of Oral Submucous Fibrosis-Derived Oral Squamous Cell Carcinoma and its Tumor Microenvironment

Immunopathogenesis of oral submucous fibrosis by chewing the areca nut

Targeting lncRNA H19/miR-29b/COL1A1 Axis Impedes Myofibroblast Activities of Precancerous Oral Submucous Fibrosis

DPSCs regulate epithelial-T cell interactions in oral submucous fibrosis

Deregulation of Secreted Frizzled-Related Proteins is Associated with Aberrant Β-Catenin Activation in the Carcinogenesis of Oral Submucous Fibrosis.

Exosomal miR-17-5p derived from epithelial cells is involved in aberrant epithelium-fibroblast crosstalk and induces the development of oral submucosal fibrosis

LINC00084/miR-204/ZEB1 Axis Mediates Myofibroblastic Differentiation Activity in Fibrotic Buccal Mucosa Fibroblasts: Therapeutic Target for Oral Submucous Fibrosis

Butylidenephthalide abrogates the myofibroblasts activation and mesenchymal transdifferentiation in oral submucous fibrosis

The functional roles of microRNAs in the pathogenesis of oral submucous fibrosis

Molecular pathways of oral submucous fibrosis and its progression to malignancy